tocilizumab,obinutuzumab,litifilimab
roche,biogen
['toci', 'derm', 'obinu', 'tocilizumab', 'litifilimab']
year in review by carol langford at #acr22: ivig in #dermatomyositis, car t cells against cd19, litifilimab, obinutuzumab, iberomide in #sle, tocilizumab in #pmr
MD PhD | Professor of #InternalMedicine | French #Vasculitis Study Group #GFEV | National Reference Center for #autoimmune diseases @HopitalCochin @Univ_Paris